Form D — SONIRE Therapeutics Inc.
0002129660-26-000001 · filed 2026-04-15
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $13,499,802
- Total sold
- $13,499,802
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SONIRE Therapeutics Inc.
- CIK
- 2129660
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 214 HOMER AVE
PALO ALTO, CA 94301 - Phone
- (650)460-9879
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Tohru Satoh · Executive OfficerPalo Alto, CA Find on LinkedIn ↗
-
Koji Yasuda · DirectorTokyo, M0 Find on LinkedIn ↗
-
Jun Okamoto · DirectorTokyo, M0 Find on LinkedIn ↗
-
Auriel August · DirectorAustin, TX Find on LinkedIn ↗
-
Dennis McWilliams · DirectorAustin, TX Find on LinkedIn ↗
View original on SEC EDGAR.